abstract |
The present invention provides compounds of formula (I) and (II) described herein: and salts thereof, and the therapeutic use of these compounds for the treatment of disorders associated with Raf kinase activity. The invention also provides pharmaceutical compositions comprising these compounds as well as compositions comprising these compounds and therapeutic co-agents. |